Urteste specialises in the development of an innovative technology allowing the detection of cancers at early stages of their development. The Urteste motto is: Early cancer detection saves lives. The company’s ground-breaking technology helps detect cancers by measuring the activity of the enzymes in urine. Urteste develops diagnostic tests for more than ten of the most common cancers. The company’s team consists of managers with wide experience in leading medical companies and scientists who specialise in the area of proteolytic enzymes and peptide chemistry.
Year founded2021
Served areaWorldwide
HeadquartersStarodworska 1, 80-137 Gdansk – Poland
PLURTST00010
LEI259400Q4S6JIKFQHGU06
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.